We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NEOG market cap is 3.65B. The company's latest EPS is USD -0.1056 and P/E is -159.47.
| Quarter End | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 | Feb 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 218.26M | 241.81M | 228.99M | 229.63M | 228.81M |
| Operating Income | 15.68M | 23.43M | 19.14M | 14.47M | 12.02M |
| Net Income | 8.19M | 5.57M | 1.5M | -3.49M | -2.02M |
| Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 414.19M | 418.17M | 468.46M | 527.16M | 822.45M |
| Operating Income | 68.09M | 67.52M | 74.17M | 58.62M | 37.52M |
| Net Income | 60.18M | 59.48M | 60.88M | 48.31M | -22.87M |
| Quarter End | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 | Feb 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.51B | 4.55B | 4.56B | 4.6B | 4.58B |
| Total Liabilities | 1.38B | 1.42B | 1.41B | 1.45B | 1.44B |
| Total Equity | 3.13B | 3.13B | 3.15B | 3.15B | 3.15B |
| Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 695.74M | 797.18M | 920.19M | 992.93M | 4.55B |
| Total Liabilities | 57.84M | 72.01M | 79.82M | 105.56M | 1.42B |
| Total Equity | 637.9M | 725.18M | 840.38M | 887.37M | 3.13B |
| Quarter End | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 | Feb 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -49.94M | 41.03M | 23.01M | 38.72M | 8.52M |
| Investing | 194.16M | 201.04M | -8.68M | 2.85M | -11.79M |
| Financing | -118.33M | -118.08M | 1.06M | 752k | 2M |
| Year End May 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 63.84M | 85.88M | 81.09M | 68.04M | 41.03M |
| Investing | -119.15M | -88.79M | -105.56M | -97.23M | 201.04M |
| Financing | 13.9M | 29.41M | 33.54M | 6.81M | -118.08M |
| Market Cap | 3.65B |
| Price to Earnings Ratio | -159.47 |
| Price to Sales Ratio | 4.44 |
| Price to Cash Ratio | 22.35 |
| Price to Book Ratio | 1.16 |
| Dividend Yield | - |
| Shares Outstanding | 216.61M |
| Average Volume (1 week) | 1.41M |
| Average Volume (1 Month) | 1.64M |
| 52 Week Change | -25.06% |
| 52 Week High | 24.095 |
| 52 Week Low | 11.46 |
| Spread (Intraday) | 4.35 (23.71%) |
| Company Name | Neogen Corporation |
| Address |
620 lesher place lansing, michigan 48912 |
| Website | https://www.neogen.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
